Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 720.57 Billion |
| USD 1,228.85 Billion | |
| % | |
|
North America Drug Delivery Market, By Type (Conventional, Advanced), Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030.
In recent years, the drug delivery market is expected to increase during the forecast period. As per WHO, chronic disease incidence is projected to rise by 57% by the end of 2020. Healthcare systems are focusing more on advanced drug delivery technologies, has risen promptly in response to the rise in chronic diseases. Additionally, there is a growing emphasis on product safety, efficacy, and patient-friendliness.
Data Bridge Market Research analyses a growth rate in the drug delivery market in the forecast period 2023-2030. The expected CAGR of the drug delivery market is tend to be around 6.90% in the mentioned forecast period. The market was valued at USD 720.57 billion in 2022, and it would grow up to USD 1228.85 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Conventional, Advanced), Route of administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), 3M (U.S.), Bayer AG (Germany), Astellas Pharma Inc. (Japan), AbbVie Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan)
|
|
Market Opportunities
|
|
Market Definition
Drug delivery builds a therapeutic effect in a human's body by leading a drug to a certain targeted place. The safety and efficacy can be amplified by adjusting the rate, time, and release of the drug in the body. Drugs can be delivered in numerous ways, that includes oral, injectable, pulmonary, nasal, and other routes. The features of nanoparticles have been studied and used to develop drug delivery systems, making the drug distribution process more effective and time-saving.
Drivers
The increasing prevalence of chronic diseases is projected to propel the drug delivery market's growth. Obesity rates are increasing as a result of the rapid change in lifestyle, leading to a slew of chronic ailments such as diabetes and heart disease.
A major factor prompting the growth rate of drug delivery market is the increasing healthcare expenditure that helps in improving its infrastructure.
Additionally, increasing initiatives by public and private organizations to spread awareness and technological advancement will enlarge the drug delivery market. Moreover, high disposable income and growing adoption of advanced drug administration systems will result in the expansion of drug delivery market.
Life expectancy is increasing around the world, that has led to a surge in the aging population. This trend positively impacts the industry by growing the occurrence of the disease and creating per capita demand for its remedies. Thus, this population demands high use of muscle relaxants and boosts market growth.
Opportunities
The market growth is driven by an increase in the number of research and development activities. This will provide advantageous opportunities for the drug delivery market growth. Along with this, increasing drug approvals and launch of innovative products will further boost the market growth rate.
Numerous product developments are initiated by several companies globally which are also accelerating the growth of market. For instance, in February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. told about the submission of a supplemental Biologics License Application (sBLA) to the U.S. FDA of DARZALEX along with Kyprolis and dexamethasone that is used to treat relapsed or refractory multiple myeloma.
Restraints/Challenges
The growth of the market is restricted by factors such as strict regulatory requirements and the risks associated with drug delivery systems. The use, separation, and development of raw materials for developing pharmaceutical and biopharmaceutical drugs demand professional and qualified personnel. Therefore, all these factors restrict the growth of the demand for the drugs.
This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
The drug delivery market is segmented on the basis of type, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Route of Administration
End-Users
Distribution Channel
The drug delivery market is analyzed and market size insights and trends are provided by product type, end-user, and distribution channel as referenced above.
The major countries covered in the drug delivery market report are the U.S., Canada and Mexico in North America.
The U.S. is dominating in the North America region due to the increase in the adoption rate of several new technological advancements in the drug delivery.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug delivery market.
Key players operating in the drug delivery market include:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.